Q4 2015 Holdings
Filed 2016-02-12 | 15 holdings | $19.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $13.2M | 721,152 | 68.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $6.0M | 259,259 | 30.9% |
| Edge Therapeutics Inc | COM | 279870109 | $22.2K | 1,933,582 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $15.9K | 1,030,954 | 0.1% |
| DBV Technologies | COM | F2927N109 | $14.1K | 230,167 | 0.1% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $11.6K | 603,031 | 0.1% |
| Alcobra Ltd | COM | M2239P109 | $7.1K | 1,130,500 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $5.4K | 420,000 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $5.4K | 369,490 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $5.0K | 1,078,932 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $4.6K | 141,611 | 0.0% |
| Cynapsus Therapeutics Inc | COM | 23257Y701 | $4.0K | 257,198 | 0.0% |
| Avalanche Biotechnologies Inc | COM | 05337G107 | $2.7K | 280,000 | 0.0% |
| ProNAI Therapeutics Inc | COM | 74346L101 | $2.6K | 175,000 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $2.0K | 315,980 | 0.0% |